Last reviewed · How we verify

Sonazoid™ — Competitive Intelligence Brief

Sonazoid™ (Sonazoid™) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Contrast agent. Area: Radiology.

phase 3 Contrast agent Radiology Small molecule Live · refreshed every 30 min

Target snapshot

Sonazoid™ (Sonazoid™) — GE Healthcare. Sonazoid is a liver-specific contrast agent that enhances the visibility of liver lesions during MRI.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Sonazoid™ TARGET Sonazoid™ GE Healthcare phase 3 Contrast agent
Imeron IOMEPROL marketed Radiographic Contrast Agent [EPC] 2024-01-01
E-Z-Hd BARIUM SULFATE marketed Radiographic Contrast Agent [EPC] 2016-01-01
Gadavist GADOBUTROL Bayer marketed Gadolinium-based Contrast Agent [EPC] 2011-01-01
Primovist GADOXETIC ACID marketed Paramagnetic Contrast Agent 2008-01-01
GADOFOSVESET GADOFOSVESET Lantheus Medcl marketed Paramagnetic Contrast Agent 2008-01-01
Optimark GADOVERSETAMIDE Liebel-Flarsheim marketed Paramagnetic Contrast Agent 1999-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Contrast agent class)

  1. Bayer · 2 drugs in this class
  2. GE Healthcare · 1 drug in this class
  3. University Hospital Muenster · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sonazoid™ — Competitive Intelligence Brief. https://druglandscape.com/ci/sonazoid. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: